Merck Aktie
137,45EUR | -0,85EUR | -0,61% |
WKN: 659990 / ISIN: DE0006599905
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 100,00 |
Massachusetts Financial Services Co. | 5,06 |
Amundi Asset Management SA (Investment Management) | 3,11 |
DWS Investment GmbH | 2,95 |
Government Pension Fund - Global (The) | 2,54 |
MFS International Equity Fund - US | 1,75 |
Vanguard Total International Stock Index Fund | 1,39 |
Vanguard Developed Markets Index Fund | 0,86 |
Vanguard Institutional Total Intl. Stock Market Index Tr. II | 0,70 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 57 036 | 58 096 | 60 334 | 64 232 | 62 908 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,28 | 0,30 | 0,33 | 0,35 | 0,33 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 9 003 | 9 280 | 10 982 | 12 201 | 12 393 |
Summe Anlagevermögen | 35 198 | 32 924 | 34 858 | 36 845 | 36 729 |
Summe Aktiva | 44 201 | 42 204 | 45 840 | 49 046 | 49 122 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 26 288 | 25 187 | 24 424 | 23 041 | 22 367 |
Summe Eigenkapital | 17 913 | 17 017 | 21 416 | 26 005 | 26 755 |
Summe Passiva | 44 201 | 42 204 | 45 840 | 49 046 | 49 122 |
Adresse
Frankfurter Strasse 250, 64293 Darmstadt | |
Telefon | +49 (6151) 72-0 |
Fax | +49 (6151) 72-5577 |
Internet | http://www.merckgroup.com/de |
Management
Albert Langenstein
Head-Controlling, Performance Materials |
Alexander Putz
Member-Supervisory Board |
Andrew Paterson
Chief Marketing Officer |
Anne Lange
Member-Supervisory Board |
Barbara Lambert
Member-Supervisory Board |
Belén Garijo López
Chairman-Executive Board & CEO |
Birgit Biermann
Member-Supervisory Board |
Christian Raabe
Member-Supervisory Board |
Constantin Fest
Head-Investor Relations |
Daniel Thelen
Member-Supervisory Board |
Danny Bar-Zohar
Head-Research & Development |
Dietmar Oeter
Member-Supervisory Board |
Gabriele Eismann
Member-Supervisory Board |
Helene von Roeder
Chief Financial Officer & Member-Executive Board |
Helga Rübsamen-Schaeff
Member-Supervisory Board |
Hong Chow
Head-China & International Healthcare |
Jeff White
Head-Surface Solutions |
Joern-Peter Halle
Chief Strategy Officer |
Jürgen Glaser
Member-Supervisory Board |
Kai Beckmann
Chief Executive Officer-Electronics |
Katherine M. Dei Cas
Head-Delivery Systems & Services |
Laura Matz
Chief Science & Technology Officer |
Martin Hostalek
Head-Group Function Environment, Health & Safety |
Matthias J. Heinzel
Chief Executive Officer-Life Science Division |
Michael Kleinemeier
Chairman-Supervisory Board |
Peter Emanuel Merck
Member-Supervisory Board |
Peter Guenter
Member-Management Board & CEO-Healthcare |
Renate Koehler
Member-Supervisory Board |
Rüdiger Weseloh
Senior Director-Business Development |
Sascha Held
Vice Chairman-Supervisory Board |
Simon Thelen
Member-Supervisory Board |